Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Treasury Shares (2023 - 2025)

CorMedix has reported Treasury Shares over the past 3 years, most recently at $2.0 million for Q4 2025.

  • Quarterly results put Treasury Shares at $2.0 million for Q4 2025, up 589.24% from a year ago — trailing twelve months through Dec 2025 was $2.0 million (up 589.24% YoY), and the annual figure for FY2025 was $2.0 million, up 589.24%.
  • Treasury Shares reached $2.0 million in Q4 2025 per CRMD's latest filing, up from $291494.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.0 million in Q4 2025 and bottomed at $103735.0 in Q3 2023.
  • Median Treasury Shares over the past 3 years was $222614.5 (2023), compared with a mean of $639516.8.
  • The largest annual shift saw Treasury Shares soared 89.61% in 2024 before it soared 589.24% in 2025.
  • Over 3 years, Treasury Shares stood at $153735.0 in 2023, then skyrocketed by 89.61% to $291494.0 in 2024, then skyrocketed by 589.24% to $2.0 million in 2025.
  • Business Quant data shows Treasury Shares for CRMD at $2.0 million in Q4 2025, $291494.0 in Q4 2024, and $153735.0 in Q4 2023.